Loading, please wait...
Date: Jun 4, 2019 12:00 PM - 01:00 PM
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on Jun 15, 2019 10:30 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
- Students
- Fellows
- Residents
- Faculty
Accreditation(s)
|
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Joint Provider(s)
Howard University Hospital - Pharmacy Department
Registration Closed
Registration Closed
Objectives
- Describe the pathophysiologyof sickle cell disease, its genotypic/phenotypic expression, complications and its prevalence in the United States
- List current non-pharmacological and pharmacological treatment modalities
- Outline L-Glutamine as a new FDA approved treatment for sickle cell disease, its safety, efficacy and administration
- Explain the place in therapy of L-Glutamine in current treatment guidelines and its implications
Speaker(s)/Author(s)
|
Dr. Akosu Owusu-Dommey, PharmD
|
Activity Number
0010-9999-19-021-L01-P
Date:
06/04/19
Time:
12:00 PM - 01:00 PM
CE Hours
1.00
Registration Closed